We have two production bases in China, located in Wujiang, Suzhou and Lingang, Shanghai.
We always prioritize the quality management of products by establishing comprehensive standards, processes and specifications to guarantee the production of high-quality products.
-
Suzhou Wujiang Production Base
-
GMP
The 1st monoclonal antibody factory in China obtained GMP Certificate based on production platform with single-use system
Obtained GMP certification in several countries/regions including China, the US, and the EU
4500 L
4,500L commercial capability
Production
Construction completed in 2016
Mainly responsible for the commercial supply of toripalimab in overseas markets
Shanghai Lingang Production Base
-
CGMP
Construction in compliance with CGMP standards. Aiming at creating an intelligent benchmark in monoclonal antibody biopharmaceutical industry
42,000L
Phase I project fermentation capability reaches 42,000L
Production
Obtained GMP Certificate in May, 2022. Responsible for investigational and commercial products‘ manufacturing